Egg Drop Syndrome 76 (EDS ’76) vaccine is indicated to protect chickens (layers, breeders, grandparents) and ducks from the EDS virus.
INDICATIONS
- Commercial Layers: To prevent sudden drops in egg production (up to 40%) and the laying of pale, thin-shelled, soft-shelled, or shell-less eggs.
- Breeders and Grandparents: To ensure consistent egg quality and production levels in breeding stock.
- Ducks: To prevent viral infection, as ducks and waterfowl are natural hosts and can spread the virus to chickens.
Multi-Antigen Indications
- MEVAC ND+EDS: Indicated for protection against both Newcastle Disease (ND) and EDS ’76.
- MEVAC ND+IB+EDS: Indicated for protection against Newcastle Disease, Infectious Bronchitis (IB), and EDS ’76.
ADMINISTRATION
- Target Population: Pullets (young hens) typically not earlier than 2 weeks of age and before the expected onset of lay.
- Common Timing: Often administered between 14 and 18 weeks of age to provide protection throughout the laying period.
- Method: Subcutaneous injection in the lower neck or intramuscular injection in the thigh or breast muscles.
Injection:
The inactivated vaccine is a liquid that is given as an injection to healthy chickens.
Location:
Can be administered either subcutaneously in the lower neck area, or intramuscularly (into the muscle) in the thigh or breast.
Dosage:
The typical dose is
0.5 mL per bird.